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neurosciences ward
Ethan G. Brown1*, S. Andrew Josephson1, Noriko Anderson2, Mary Reid1, Melissa Lee1 and Vanja C. Douglas1
Abstract
Background: Delirium is a frequent and detrimental complication of inpatient hospitalization. Multicomponent
intervention in selected groups has been shown to prevent and treat delirium, though little data exists on
the effect of intervention in neurological patients. We studied the efficacy of a multicomponent delirium care
pathway implemented on a largely neurology and neurosurgery hospital ward among unselected patients.
Methods: We incorporated a multicomponent delirium care pathway into the workflow of a university hospital for
patients older than 50 years. The pathway involved risk-stratification for development of delirium, delirium screening,
and non-pharmacologic behavioral prevention and intervention. We then retrospectively reviewed admissions before
and after implementation of the care pathway. Our primary endpoint was incidence of delirium; secondary endpoints
included delirium days, length of stay, restraint use, readmission rates, and discharge disposition.
Results: Seven hundred ninety eight admissions from before the delirium care pathway went into effect and 797
admissions from afterwards were reviewed. Baseline characteristics between groups were similar. Delirium incidence
between the two groups did not change (7.0% before vs 7.2% after, p = 0.89). Length of stay among delirious patients
significantly decreased after implementation of the delirium care pathway (9.60 before vs 7.06 after, β = − 0.16, adjusted
p-value = 0.001).
Conclusion: Implementation of a delirium care pathway on a neurosciences ward was not associated with changes in
the rate of delirium development, though length of stay among delirious patients decreased. In a largely neurologic
population, multicomponent intervention to prevent and treat delirium may not change delirium incidence, but may
be effective in mitigating delirium complications.
Keywords: Delirium, Patient safety, Outcome research, Cognitive aging
Background
Multi-component, non-pharmacologic interventions both
prevent the development and mitigate the complications of
inpatient delirium [1, 2], but their efficacy has not been
studied in neurologic populations. Neurologic patients are
at high risk of delirium, with neurologic emergency rooms,
wards, and stroke units seeing rates of delirium ranging
from 11 to 16% [3–5]. Delirium has been associated with a
longer length of stay on a neurology ward, worse outcome
after stroke, and acceleration of cognitive decline in patients
with dementia [3, 5, 6].
Over the last decade, multi-component interventions
implemented by hospital staff have been shown to reduce
rates and detrimental outcomes of delirium in many set-
tings [2, 7]. These interventions include frequent reorienta-
tion, early mobilization, improvement in sleep regulation,
ensuring adequate hydration, treating urinary retention
and constipation, and ensuring hearing and visual aids are
present if needed [1].
Despite the efficacy of the multicomponent approach,
few studies have examined these interventions in patients
with neurologic pathology. Delirium in neurology and
neurosurgery patients may be similar to general medicine
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cases. On the other hand, acute confusion in the setting of
an underlying lesion in the central nervous system may be
much less modifiable with non-pharmacologic interven-
tions. Furthermore, the systematic changes that previous
protocols have implemented require increased staffing to
help with screening and treatment. A protocol that does
not require any additional staff would be ideal, and may be
most feasible on a neurosciences unit where nurses and
other staff are specifically trained in cognitive assessment.
To address these issues, we developed a delirium care
pathway for the neurosciences ward at a university medical
center. The care pathway screened for the risk and presence
of delirium, and implemented non-pharmacologic interven-
tions to those patients at high risk of developing delirium
and to those who had already developed delirium. To
measure the efficacy of this intervention, we compared the
incidence of delirium and its secondary clinical outcomes
before and after the pathway was put in place.
Methods
We conducted a retrospective cohort study investigating
the clinical efficacy of a comprehensive delirium care
pathway instituted on the neurosciences ward of the
University of California San Francisco Medical Center.
The intervention was implemented on the neurosciences
ward as part of a department-wide effort to improve de-
lirium care. The study was planned prior to implementa-
tion of the care pathway, but data collection and analysis
was retrospective. The ward is staffed with nurses
trained in neurological assessment, and patients are
largely neurology and neurosurgery, though patients on
other services may board on this floor as well.
Intervention
All patients who were admitted to the neurosciences floor
and were over the age of 50 years were enrolled in the care
pathway, as depicted in Fig. 1. First, nursing staff would
calculate the AWOL prediction score, which stratifies pa-
tients based on their risk of delirium [8]. While this score
was historically developed and initially validated in hospi-
talized medical patients, we separately validated the use-
fulness of this score in neurological patients using a subset
of patients in this cohort [9]. In our study the area under
the receiver operating characteristic curve for predicting
delirium was 0.83, suggesting good predictive value. If a
patient was found to be at increased risk of developing de-
lirium (defined as an AWOL score ≥ 2, based on maximiz-
ing sensitivity and specificity from previous studies [8, 9]),
staff would employ evidence-based non-pharmacologic
delirium prevention measures, including but not limited
to frequent re-orientation, regulating sleep-wake cycles,
and reducing restraints, lines, and catheters as possible.
These strategies were derived from the National Institute
for Health and Care Excellence (NICE) Guidelines [10].
While application of these guidelines to all patients
would be ideal, this algorithm served to focus nursing ef-
forts on particularly high-risk patients. All patients, re-
gardless of risk-level, were screened for delirium by their
nurse once during every twelve-hour shift using the con-
fusion assessment method (CAM), a validated method for
detecting delirium [11]. If a patient screened positive for
delirium, his or her nurse would notify the primary team,
the pharmacist, and initiate a neurology consultation to
assist with management of delirium. In addition, they
would ensure non-pharmacologic management strategies
were taking place. Pharmacy and neurology staff had dis-
cussions to coordinate recommendations regarding delir-
ium care, with attention to avoiding high-risk medications
and addressing common exacerbating factors.
Study design
The delirium care pathway was started on November
1st, 2013. To investigate its effect, we examined patients
admitted before and after the care pathway was imple-
mented. Our ‘before’ study period included admissions
from November 1st, 2012 through October 31st, 2013;
our ‘after’ group began following a run-in period of
6 months, spanning April 1st 2014 through March 30th,
2015. Any patient whose date of admission to the
Fig. 1 The delirium care pathway (DCP) flow diagram. See text for
description of AWOL. CAM = confusion assessment method
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neurosciences ward fell during these epochs and was
over 50 years old was included as a potential subject.
Case ascertainment
After implementation of the care pathway, nursing staff
identified cases of delirium through use of the CAM,
but for this study delirium was identified without con-
sideration of the CAM. Rather, delirium was identified
based on any reported mental status changes docu-
mented in the notes of the chart. We chose this method
for two reasons: first, before the delirium care pathway
intervention, none of the subjects had CAM scores, and
we wanted a consistent method for detecting delirium
between the two groups. Secondly, active screening
through the CAM could naturally increase the detection
rate of delirium, leading to over diagnosis in the cohort
after the pathway was introduced. Health care provider
documentation, while potentially influenced by the care
pathway, should be less affected, and still communicate
similar information about the patient in both settings.
This method of chart review to detect delirium has
been previously validated with a sensitivity of 74% and
specificity of 83% when compared to interviewer-based
methods [12]. Chart reviews were performed by one in-
vestigator (E.G.B.). A subset of charts was reviewed by
the senior investigator (V.C.D.) to internally validate the
methodology. Charts where the delirium diagnosis was
uncertain were adjudicated by the investigators. Blinding
to the care epoch was not possible because the medical
record could not be reviewed with the dates removed.
All physician and nursing notes were reviewed for the
presence of absence of delirium, the start and end dates,
the subtype (hyperactive versus hypoactive), who diag-
nosed the delirium, and any potential cause if identified.
To assess the accuracy of the chart review method, delir-
ium diagnosis by chart review was compared to the
CAM assessment of bedside nurses. We also reviewed
the past medical history available in the notes and prob-
lem list to calculate a Charlson comorbidity index [13],
and made special note of a history of psychiatric disease
or epilepsy. If the family or admitting physician noted a
history of long-term difficulty with thinking, or if there
was a formal diagnosis of dementia in the problem list,
then the subject was recorded as having prior cognitive
impairment. While delirium may be a particularly detri-
mental complication in patients with dementia and iden-
tifying this subgroup is particularly important [6], the
level of detail available in the chart did not allow for the
distinction from those patients with mild cognitive im-
pairment. We also collected demographic information,
dates of admission, transfers, and discharge, hospital ser-
vice at admission, 30-day readmission rates to our med-
ical center, presence and duration of restraint or sitter
use, and discharge disposition. The results of the AWOL
prediction score and the CAM were extracted. In deliri-
ous patients, the use of antipsychotics, benzodiazepines,
or other sleep aids was recorded.
Delirium prevalence vs incidence
Our primary outcome was the change in incidence of
hospital-acquired delirium on the neurosciences unit be-
fore and after the delirium care pathway was imple-
mented. As the delirium care pathway was in use only
on the neurosciences ward, we restricted the primary
outcome to delirium that developed on that floor only,
or ‘Incident Delirium.’ A subject was classified with inci-
dent delirium if he or she was admitted to the neurosci-
ences ward without any mental status abnormality, and
subsequently developed delirium while on the neurosci-
ences ward. Any subject who was admitted.
or transferred to the neurosciences unit having already
developed delirium, either before admission or on another
unit, was considered ‘prevalent delirium.’ While the pri-
mary outcome was limited to incident delirium, secondary
outcomes, which included delirium duration, overall
length of stay, restraint use, sitter use, disposition to nurs-
ing facility, and 30-day readmission rate, were analyzed in
subjects with either incident or prevalent delirium, as we
expected the care pathway to have some beneficial effect
on all cases of delirium. Restraint and sitter use included
use of these measures on the neurosciences ward only.
Statistical analysis
Previous studies have shown that non-pharmacologic inter-
ventions can prevent one third of delirium cases. Therefore
our sample size calculation was based on an estimated re-
duction of delirium incidence from 12% to 8% of inpatient
hospitalizations, with α = 0.05 and β = 0.80; to show this dif-
ference required review of 1600 hospital admissions, 800
from before the delirium care pathway and 800 from after-
wards. We did not restrict the admissions to unique pa-
tients, as we wanted to assess the care pathway in all
patients, regardless of any history of delirium or hospital
admission. Furthermore, we could not record recent admis-
sions or delirium episodes in other hospitals, so restricting
the population to unique patients may have biased our
sample. Overall, there were 2138 eligible admissions before
the care pathway and 2151 potential admissions afterwards.
We randomly selected 800 admissions from before (using
the “rand” function in Microsoft Excel 2010 version 2.0).
We then sorted the admissions from after the care pathway
into 10-year age groups (50–59, 60–69, 70–79, 80–89, and
> 90). Finally, we randomly selected the same number of
subjects from within each age group as were represented in
the admissions from before the pathway, in order to have
similar age distributions in each cohort.
Because some of our analyses involved some re-
admissions of the same patient, we could not assume
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each observation was independent and needed to ac-
count for repeated measures in evaluation of our out-
come. For analyses that included repeated measures we
used a generalized estimating equations model (GEE),
which accounts for potential correlations among clus-
tered observations. A logistic link function was used for
binary outcomes. For continuous outcomes such as
length of stay, an identity link function was used. We
used natural log transformations of continuous variables
to reduce positive skew and to approximate a normal
distribution, generating ratios of geometric means. For
all outcomes where repeated admissions were excluded,
such as our descriptive data in Tables 1 and 2, a Chi-
square test or Wilcoxon’s rank sum test was used for
categorical or non-parametric continuous data, respect-
ively. A bivariate analysis was done to search for con-
founders. In addition to any potential confounders, we
performed multivariable models with clinically relevant
factors including age at admission, gender, the presence
of prior cognitive impairment, and Charlson comorbidity
index [13]. Many of these characteristics have been pre-
viously identified as risk factors for delirium and were
therefore kept in our model [14]. For length-of-stay, we
ran secondary multivariable regressions using the out-
come variable without outliers (defined as more than 3
standard-deviations from the mean) and after log-
transformation, both with similar significant results.
Given that we were testing 9 hypotheses, we used the
Bonferroni correction and statistical significance for all
outcomes was set at α < (0.05/9) = 0.006. All statistical
analyses were performed using a licensed copy of
STATA, version 13.1 [15].
Results
Description of subjects
Of 1600 charts chosen for review, 798 admissions were
reviewed in the pre-intervention group (two charts were
restricted), and 797 in the after-group (two charts were
restricted, and one subject was under 50 years old at
time of admission). The mean age of the groups was simi-
lar (67.1 +/− 11.1 before and 67.1 +/− 11.2 after, p = 0.89),
as were the ratio of men to women and the rate of cogni-
tive impairment prior to admission, though there were
more Hispanic patients in the pre-intervention group
(Table 1). More than 2/3 of patients were on either the
neurosurgical or neurology service in both epochs. Char-
acteristics in patients with delirium only are shown in
Table 2. There was a significant difference between hos-
pital services in the pre-intervention group compared to
the post-intervention group (p = 0.014) among delirious
patients only, but otherwise demographic information was
similar between epochs.
Table 1 Subject characteristics before and after implementation
of the delirium care pathway in all patients
Before Care
Pathway
(n = 752
patients)
After Care
Pathway
(n = 749
patients)
p-value
Age, median (IQR) 67 (59–74) 67 (58–75) 0.89
Female, no. (%) 399 (53) 380 (51) 0.37
Race, no. (%) 0.365
White 470 (63) 456 (61)
Black 49 (6.5) 49 (6.5)
Asian / Pacific Islander 129 (17) 130 (17)
Other / Unknown 104 (14) 114 (15)
Hispanic 70 (9.3) 61 (8.1) 0.027
Modified Charlson
comorbidity score,
median (IQR)
4 (2–5) 4 (2–5) 0.22
Prior cognitive
impairment, no. (%)
119 (16) 115 (15) 0.80
Primary Hospital Service,
no. (%)
0.64
Neurology 163 (22) 168 (22)
Neurosurgery 359 (48) 365 (49)
Hospital medicine 137 (18) 138 (18)
Other 93 (12) 78 (10)
mCCM modified Charlson comorbidity score
Table 2 Subject characteristics before and after implementation
of the delirium care pathway in delirious patients only
Before Care
Pathway
(n = 197
patients)
After Care
Pathway
(n = 194
patients)
p-value
Age, median (IQR) 71 (62–80) 72 (64–81) 0.77
Female, no. (%) 112 (57) 96 (49) 0.14
Race, no. (%) 0.92
White 111 (56) 107 (55)
Black 12 (6.1) 11 (5.7)
Asian / Pacific Islander 42 (21) 50 (26)
Other / Unknown 32 (16) 26 (13)
Hispanic 23 (12) 13 (6.7) 0.24
Modified Charlson
comorbidity score,
median (IQR)
5 (3–6) 5 (3–6) 0.83
Prior cognitive impairment, no. (%) 65 (33) 61 (31) 0.74
Primary Hospital Service, no. (%) 0.014
Neurology 54 (27) 65 (34)
Neurosurgery 102 (52) 91 (47)
Hospital medicine 29 (15) 36 (19)
Other 12 (6.1) 2 (1.0)
mCCM modified Charlson comorbidity score
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Incidence and prevalence of delirium
Overall, 213 (27%) patient admissions involved delirium
before implementation of the delirium care pathway,
while 204 (26%) of patient admissions involved delirium
afterwards (Table 3). Slightly more involved prevalent
delirium in the pre-intervention group, though the dif-
ference was not significant (21% vs 20%, p = 0.60). The
overall rate of incident delirium did not change between
admissions before and after the delirium care pathway
was implemented (7.0% before the delirium care path-
way vs 7.2% after, p = 0.53).
While the majority of the patients in whom the care
pathway was implemented were neurology and neuro-
surgery patients, a significant proportion (28%) were
non-neurology patients. To examine the effect of the care
pathway in neurology and neurosurgery patients alone, we
repeated the analysis in admissions to neurology and
neurosurgical services (n = 552 before implementation
and n = 571 afterwards). Neither prevalence nor incidence
of delirium significantly changed (prevalence: 25% before
and 21% after, p = 0.24; incidence: 7.7% before and 8.9%
after, p = 0.54). We also evaluated the care pathway among
cognitively impaired patients, a particularly high-risk
group (n = 126 admissions before and after implementa-
tion of the care pathway). The results were similar (preva-
lence: 44% before and 43% after, p = 0.72; incidence: 18.6%
before and 18.1% after, p = 0.97).
Secondary outcomes
For secondary outcomes, we examined subjects with delir-
ium only. Length of stay decreased by more than 2 days
among delirious patients after the delirium care pathway
was implemented, even after adjustment for age, gender,
prior cognitive impairment, and comorbidity (9.60 vs 7.06,
β = − 0.072, adjusted p-value = 0.008; Table 4). The
relationship was still significant (β = − 0.076, adjusted
p-value = 0.005) after further adjustment for inpatient
hospital service.
Importantly, length of stay in patients without delir-
ium did not significantly change (3.6 +/− 3.4 before and
3.7 +/− 2.9, p = 0.75). There was a reduction in delirium
days after the care plan was implemented, though this
difference was not statistically significant after adjusting
for age, comorbidity, gender, and cognitive impairment
(5.4 vs. 4.2 days, p = 0.647; Table 4). We also examined
these outcomes in delirious neurology and neurosurgery
patients alone. In this population length of stay similarly
shortened, from 11.0 days to 7.7 days (β = − 0.10, ad-
justed p-value < 0.001). Length of stay in non-delirious
patients in this population did not change (4.0 vs
3.8 days, p = 0.339). Among delirious patients with prior
cognitive impairment, length of stay decreased from
8.2 days to 6 days, though this change was not signifi-
cant (adjusted p-value = 0.25). Still, this represented a
larger change than in non-delirious patients with prior
cognitive impairment (4.5 vs 4.0, p = 0.45). Finally, as not
all of the admissions involved unique cases, we per-
formed a sensitivity analysis including only the first ad-
mission for delirious patients (n = 389 patients). We
found that length of stay similarly decreased when only
these hospital stays were included (9.50 days before vs
7.06 days after, β = − 0.17, adjusted p-value = 0.001).
Restraint use (17% before vs 14% after, p = 0.57) and sit-
ter use (31% before vs 25% after, p = 0.18) both showed
non-significant declines after implementation of the care
pathway (Table 4). Thirty-day readmission rates decreased
from 11% before the pathway to 5.4% afterwards, though
the difference was not statistically significant (p = 0.16).
Table 3 Outcomes before and after implementation of the
delirium care pathway among all admissions
Before care pathway
(n = 798 admissions)
After care pathway
(n = 797 admissions)
p-value
Prevalent
Delirium, no. (%)
169 (21) 158 (20) 0.60
Incident
Delirium, no. (%)
44 (7.0) 46 (7.2) 0.53
LOS, mean days
(SD)
5.2 (6.2) 4.5 (4.1) 0.339
Restrained, no.
(%)
38 (4.8) 30 (3.8) 0.52
Days restrained,
mean days (SD)
5.7 (6.2) 4.3 (4.5) 0.305
Sitter, no. (%) 89 (11) 81 (10) 0.31
Readmissions,
no. (%)
69 (8) 64 (8) 0.53
Disposition to
SNF, no. (%)
88 (11) 95 (12) 0.36
LOS length of stay, SNF skilled nursing facility
Table 4 Outcomes before and after implementation of the
delirium care pathway in admissions involving delirium only
Before care
pathway (n = 213
admissions)
After care
pathway (n = 204
admissions)
Unadjusted
p-value
LOS, mean days
(SD)
9.60 (9.3) 7.05 (5.7) 0.013
Restrained, no. (%) 36 (17) 29 (14) 0.57
Days restrained on
the ward, mean
days (SD)
5.8 (6.4) 4.4 (4.5) 0.337
Sitter, no. (%) 67 (31) 51 (25) 0.18
Readmissions, no.
(%)
24 (11) 11 (5.4) 0.16
Disposition to SNF,
no. (%)
55 (26) 55 (27) 0.76
Delirium Days on
ward, mean days
(SD)
5.4 (5.7) 4.2 (3.5) 0.947
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Assessment of case ascertainment
Finally, we assessed our method of identifying cases of de-
lirium through chart review, as this method has only been
previously validated in general medical patients [12]. Com-
pared to the diagnosis of delirium by the CAM performed
by bedside nurses our chart-review delirium method
showed a sensitivity of 76.3% and a specificity of 80.5%.
Discussion
We demonstrated successful implementation of a multi-
component delirium care pathway on a neurosciences
ward. While we did not find a change in the incidence
of delirium after initiation of the care pathway, a re-
duced length of stay was observed among delirious pa-
tients, significant at our Bonferroni corrected threshold
of an adjusted p < 0.006. These findings held true when
the analysis was restricted to only neurology and neuro-
surgery patients.
The lack of reduction in incidence is unusual for a multi-
component pathway [7], and could be due to a number of
reasons. One explanation may lie in the unique patient
population of our study. The patients were primarily neur-
ology and neurosurgery patients, with some hospital medi-
cine and a minority of other surgical patients. As opposed to
a general medical or surgical ward, where multi-component
delirium interventions have been studied, delirium on a neu-
rosciences ward may be less affected by addressing trad-
itional risk factors. For instance, confusion from infection
on a medical ward or immobility on an orthopedic surgery
ward may be prevented by rehydration or physical therapy,
respectively. On the other hand, altered mental status from
an intracranial mass or post-ictal encephalopathy may occur
regardless of all non-pharmacologic prevention efforts. This
difference is important to consider for future multicompo-
nent intervention models.
The incidence may also have been affected by the study
design: as the care pathway included routine screening for
delirium, increased awareness and detection of delirium
may have led to an increase in identification of delirium in
the post-intervention group, despite our attempt to miti-
gate detection bias by using a chart review method to
identify delirium in both the pre- and post-intervention
groups. However, because the incidence was similar be-
tween the two groups, either the care pathway had no ef-
fect on incidence or a beneficial effect was masked by an
increase in delirium identification after the intervention.
Even if delirium incidence is not modifiable in neurosci-
ence patients, multi-component intervention may mitigate
the severity of delirium and its secondary effects regard-
less of its cause. In our study, the reduction in length of
stay after the introduction of the care pathway is encour-
aging. It is unlikely that length of stay was reduced simply
because of a general effort to discharge patients earlier
over the time period of the study, since there was no
reduction in length of stay for non-delirious patients. Dif-
ferences in the study population likely did not contribute,
as adjusted models were also significant. Finally the lack
of increase in readmission rates indicates that patients
were not necessarily discharged early inappropriately. A
lack of increase in length of stay among delirious neuro-
logical patients and patients with prior cognitive impair-
ment is reassuring and suggests that the care pathway
may be effective in these settings.
The reduction of length of stay of more than 2 days
likely diminishes risk of further inpatient complications
and caregiver stress while substantially reducing costs. Re-
duced length of stay is associated with lower likelihood of
readmission and lower all-cause mortality over time in
medical patients [16]. In delirium, previous multicompo-
nent interventions that reduced length of stay to a similar
degree saw significant cost savings, even when the pathway
involved additional staffing [17]. Cost of hospitalization was
not available for our study, however the national average
cost of a day in the hospital for patients over 45 years old is
$2480, according to 2012 estimates [18]. With 2151 hospi-
talizations on our unit over the year we examined, and
using the rate of delirium we detected of 26%, a 2.5-day re-
duction in hospital stay translates to savings of 3.4 million
dollars yearly. While an estimate, the true savings are likely
substantial, especially in the face of no added cost without
any additional staff.
The reduction in length of stay may reflect a more rapid
resolution of delirium with the care pathway, as suggested
by the non-significant reduction in delirium duration we
found after the care pathway was implemented. Our care
pathway placed a particular emphasis on reducing the use
of sedatives to treat delirium, which may have been a fac-
tor in reducing delirium duration, contributed to im-
proved return to normal sleep-wake cycles, and increased
opportunities for early mobility. The reduction in length
of stay may also have been related to an increased level of
comfort with discharging patients who were still mildly
delirious, due to education of caregivers, nurses, and pro-
viders that delirious patients generally fare better at home
than in hospital once the underlying cause of their delir-
ium has been addressed.
The care pathway was associated with improvement in
most secondary outcomes, although only the reduction in
readmission rate showed a p < 0.05 in univariate analysis,
and no secondary outcomes were significant at our more
stringent statistical cutoff. Still, the trend for many of
these is positive, including the number of delirium days,
the use of sitters and the use of restraints. These are all
clinically meaningful differences, and the study was under-
powered to show changes in such infrequent events. Other
studies evaluating multicomponent interventions for delir-
ium have often focused on different secondary outcomes,
and not highlighted these features of the hospitalization
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[7]. Bakker et al. [19] reported a non-significant increase in
readmission after non-pharmacologic intervention. Chong
et al. [20] reduced restraints completely, though only
through the use of separate geriatrics unit; Avendano-
Cespedes et al. [21] reported a non-significant trend to-
wards less restraint use in their multidisciplinary interven-
tion. Overall the findings in our study are encouraging, and
they reinforce the need for these characteristics to be an
outcome in future studies.
While several previous studies have shown improve-
ment in delirium after incorporation of a multicomponent
pathway [1, 22, 23], the delirium care pathway we imple-
mented has some advantages. We did not require add-
itional staffing for the behavioral interventions and
screening, or the use of a specialized geriatric ward. Both
medical and surgical patients were included, and nursing
staff used a risk stratification tool that required very little
additional patient assessment (< 2 min [8]), which allowed
for efficient triaging of resources. These elements make
the delirium care pathway more efficient for nursing staff
with limited resources and time, allowing for more effi-
cient integration of the protocol into hospital workflow.
Our study had several important limitations. We used
a chart review method for detecting delirium, which was
initially validated in an elderly medical population and
therefore may not be generalizable to our population
[12]. As we describe above, the sensitivity and specificity
in our cohort, when using the CAM as the gold stand-
ard, were similar to that found the original study. In fur-
ther support of chart abstraction as a mechanism for
identifying delirium, a similar method was validated in a
separate population, using the medical records system of
the United Kingdom [24]; in this study, the sensitivity
and specificity of identifying probable delirium was 58
and 93%, respectively. While the chart-review method
may mischaracterize patients from lack of documenta-
tion, later studies have shown some benefits of using
chart review, such as being able to evaluate the patient
at multiple times of day, a challenging breadth for
interview-based methods to achieve [25].
Still the chart-review method has reduced sensitivity,
which may have limited our ability to detect all delirium
cases. However, this likely affected the measured delirium
incidence in both epochs equally, unless increased nursing
screening led to more recognition and documentation of
delirium in the chart notes. Detection of more subtle cases
after care pathway implementation may have led to a
falsely low change in delirium incidence but falsely high
change in length of stay. On the other hand, an increased
rate of false-negatives in the period before care pathway
implementation may have led us to underestimate our
length of stay for these patients, making the true effect of
the pathway larger than reported. We tried to make our
detection rates as similar as possible between epochs by
having one investigator review all charts (E.G.B.), defining
delirium as objectively as possible (based on key words in
the chart), not using the CAM to detect delirium, and ad-
judicating challenging cases. Ideally the investigator
reviewing the charts would be blinded to group, but the
nature of chart review precluded this strategy.
Furthermore, compliance with individual components
of the care pathway was not measured during the study.
Therefore we were unable to test whether patients who
received more aspects of the multi-component interven-
tion were more likely to have improved outcomes. Fi-
nally, as with any study using a before/after design, we
cannot rule out the observation of reduced length of stay
being due to other unmeasured variables. These limita-
tions would be better controlled through a randomized
controlled trial, which would be helpful in this popula-
tion of patients to understand the benefit of multicom-
ponent intervention.
The need for addressing delirium during inpatient
hospitalization is clear, and based on available evidence
multicomponent pathways are currently our safest and
most effective tool. This study suggests implementation of
such a pathway on a neurosciences ward can modify the
outcomes of delirium, particularly length of stay, but also
calls attention to the potential differences between neuro-
logical patients and general medical or surgical patients.
Conclusions
A multicomponent delirium care pathway involving active
risk stratification and screening of delirium was intro-
duced on the neurosciences ward at our institution. We
did not find any changes in delirium incidence after the
care pathway was implemented, but length of stay signifi-
cantly decreased among delirious patients, while other
secondary outcomes such as readmissions and sitter
utilization showed a trend towards improvement. This
suggests that multicomponent interventions to prevent
and treat delirium in a population of largely neurology in-
patients may not change delirium incidence, but may be
effective in mitigating its complications.
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